ArrowMark Partners
Overview
ArrowMark Partners is an employee-owned investment management firm that focuses on niche and less efficient market segments in public and private credit, equity, leveraged loans, and middle-market commercial real estate finance.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Dren Bio | Oct 2026 | Early Funding | Co-investor |
| Poplar Therapeutics | Mar 2026 | Series A Extension | Co-investor |
| Skyryse | Feb 2026 | Series C | Co-investor |
| Arbor Biotechnologies | Mar 2025 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Brian Schaub
Partner, Portfolio Manager
Karen Reidy
Partner
Robin Beery
Partner
Mark Godfrey
Director, Investor Relations
Chris Dunne
Principal - Business Development And Client Engagement
George Braun
Principal
Logan Heidmann
Principal Investments - Commercial Real Estate
Rick Grove
Principal Compliance Officer
Timothy J. Beresford
Principal
Chad Meade
Portfolio Manager
Clayton Freeman
Portfolio Manager
Clint Chafin
Portfolio Manager
Maneesh Modi
Portfolio Manager
Rick Whipple
Equity Client Portfolio Manager
Tony Yao
Portfolio Manager
Scott Kudrick
Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ArrowMark Partners based?
ArrowMark Partners is headquartered in Denver, Colorado, United States.
When was ArrowMark Partners founded?
ArrowMark Partners was founded in 2007.
How many portfolio companies does ArrowMark Partners have?
ArrowMark Partners has 37 portfolio companies in Caplight's dataset.
What are some companies in ArrowMark Partners's portfolio?
Recent investments visible on Caplight include Dren Bio, Poplar Therapeutics, Skyryse, Poplar Therapeutics, Arbor Biotechnologies.
What was ArrowMark Partners's most recent investment?
ArrowMark Partners's most recent investment on Caplight was in Dren Bio in 2026.
What sectors does ArrowMark Partners focus on?
ArrowMark Partners focuses on Real Estate & PropTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Real Estate & PropTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Telecommunications & Networking, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, Real Estate & PropTech, Healthcare & Life Sciences, Cybersecurity, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Cybersecurity, Mobility, Transportation & Logistics, Enterprise Software, Frontier & Industrial Tech, Energy & Sustainability, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Real Estate & PropTech, Consumer & Commerce, Telecommunications & Networking, Frontier & Industrial Tech, Media, Entertainment & Gaming, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does ArrowMark Partners focus on?
ArrowMark Partners typically invests at the Mid stage.
What is ArrowMark Partners's AUM?
ArrowMark Partners's assets under management are estimated between $500.0M and $1.0B.